This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is It Worth Investing in Ares Capital (ARCC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Ares Capital (ARCC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ARCCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Star Bulk Carriers (SBLK): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Star Bulk Carriers (SBLK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SBLKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Chipotle (CMG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Chipotle (CMG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CMGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Spotify (SPOT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Spotify (SPOT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SPOTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is New Gold (NGD) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in New Gold (NGD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NGDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Rio Tinto (RIO) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Rio Tinto (RIO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RIONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Lilly (LLY) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Lilly (LLY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LLYPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in PDD Holdings Inc. Sponsored ADR (PDD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PDD Holdings Inc. Sponsored ADR (PDD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PDDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Groupon (GRPN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Groupon (GRPN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
GRPNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Take-Two (TTWO) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Take-Two (TTWO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TTWONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Emerson Electric (EMR) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Emerson Electric (EMR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
EMRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in CrowdStrike (CRWD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CrowdStrike (CRWD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRWDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Adobe (ADBE): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Adobe (ADBE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ADBENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Pure Storage (PSTG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Pure Storage (PSTG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PSTGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Lowe's (LOW) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Lowe's (LOW) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LOWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in RCM Technologies (RCMT): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for RCM Technologies (RCMT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RCMTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See ACM Research (ACMR) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in ACM Research (ACMR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ACMRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Intuitive Surgical (ISRG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ISRGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Norwegian Cruise Line (NCLH) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Norwegian Cruise Line (NCLH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NCLHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Duke Energy (DUK): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Duke Energy (DUK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
DUKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
On Holding (ONON) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for On Holding (ONON) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ONONNo Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Diebold Nixdorf, Incorporated (DBD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Diebold Nixdorf, Incorporated (DBD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
DBDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Viking Therapeutics (VKTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
VKTXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Nu (NU): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Nu (NU). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Intuit (INTU): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Intuit (INTU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
INTUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth